OMD and type 2 diabetes mellitus: In this regard, results from an unbiased plasma proteomic profiling of a large CVD cohort indicated osteomodulin (OMD, also termed osteoadherin) as one of the potential novel circulating biomarkers associated with cardiovascular risk traits16 and type 2 diabetes.17